Theriva Biologics Inc (AMEX:TOVX)
$ 1.47 -0.11 (-6.96%) Market Cap: 4.09 Mil Enterprise Value: -10.27 Mil PE Ratio: 0 PB Ratio: 0.16 GF Score: 30/100

Q1 2022 Synthetic Biologics Inc Earnings Call Transcript

May 16, 2022 / 12:30PM GMT
Release Date Price: $57.6 (+0.61%)
Operator

Greetings, and welcome to Synthetic Biologics' First Quarter 2022 Earnings Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.

I would now like to turn the conference over to your host, Dean Schwartz of LifeSci Advisors. Please go ahead, sir.

Dean Schwartz

Thank you, operator, and good morning, everyone. Welcome to Synthetic Biologics' 2022 First Quarter Investor Conference Call. Leading the call today will be Steven Shallcross, Chief Executive and Chief Financial Officer of Synthetic Biologics; Dr. Vince Wacher, Head of Corporate and Product Development of Synthetic Biologics; Dr. Manel Cascalló, General Director of Synthetic Biologics, European subsidiary; and Dr. Frank Tufaro, Chief Operating Officer, are also on the call and will be available to answer questions during the Q&A session.

Synthetic Biologics issued a press release this morning, which provided operational highlights and included the financial results for the first quarter ending March 31, 2022. The press release can be found in the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot